Daniel C. Javitt, MD, PhD

Articles

Glutamate and Schizophrenia: From Theory to Treatment Implications

September 20, 2014

Glutamatergic models have led to greater understanding of the causes of social and occupational disability in schizophrenia, and thus have provided new targets for remediation and compensation strategies.